Identification of HLA-A*0201-restricted CD8 + T-cell epitope C 64-72 from hepatitis B virus core protein

International Immunopharmacology

Volumn 13, Issue 2, 2012, Pages 141-147

  Liu, Qiuyan ^a   Zheng, Yuanyuan ^a   Yu, Yizhi ^a   Tan, Qinchun ^b   Huang, Xinping ^c  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Cytotoxic T lymphocyte; Epitope; HBcAg; HLA A*0201; Interferon

Indexed keywords

EPITOPE; GAMMA INTERFERON; GRANZYME B; HEPATITIS B CORE ANTIGEN; HLA A ANTIGEN; HLA A2 ANTIGEN; PERFORIN; TETRAMER; CORE PROTEIN; GRANZYME; HLA A*02:01 ANTIGEN; HLA-A*02:01 ANTIGEN;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; BINDING AFFINITY; BINDING ASSAY; CD8+ T LYMPHOCYTE; CELL POPULATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DENDRITIC CELL; ENZYME LINKED IMMUNOSPOT ASSAY; HEPATITIS B; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; AMINO ACID SEQUENCE; ANIMAL; BIOSYNTHESIS; CYTOTOXIC T LYMPHOCYTE; EPITOPE MAPPING; GENETICS; HEPATITIS B VIRUS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; TRANSGENIC MOUSE; VIROLOGY;

AMINO ACID SEQUENCE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; GRANZYMES; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HLA-A2 ANTIGEN; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE; MICE, TRANSGENIC; PERFORIN; T-LYMPHOCYTES, CYTOTOXIC; VIRAL CORE PROTEINS;

EID: 84860369229     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.03.018     Document Type: Article

References (56)

1. F.V. Chisari, and C. Ferrari Hepatitis B virus immunopathogenesis Annu Rev Immunol 13 1995 29 60
2. R.P. Beasley, L.Y. Hwang, C.C. Lin, and C.S. Chien Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22707 men in Taiwan Lancet 2 1981 1129 1133
3. World Health Organization Department of communicable diseases surveillance and response, WHO/CDS/CSR/LYO http://www.who.int/emc 2002
4. L.G. Guidotti, and F.V. Chisari Immunobiology and pathogenesis of viral hepatitis Annu Rev Pathol 1 2006 23 61
5. A.R. Zanetti, P. Van Damme, and D. Shouval The global impact of vaccination against hepatitis B: a historical overview Vaccine 26 2008 6266 6273
6. F.S. Wang, and Z. Zhang Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus Expert Rev Gastroenterol Hepatol 3 2009 499 512
7. B. Rehermann, P. Fowler, J. Sidney, J. Person, A. Redeker, and M. Brown The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis J Exp Med 181 1995 1047 1058
8. L.G. Guidotti, T. Ishikawa, M.V. Hobbs, B. Matzke, R. Schreiber, and F.V. Chisari Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes Immunity 4 1996 25 36
9. R. Nayersina, P. Fowler, S. Guilhot, G. Missale, A. Cerny, and H.J. Schlicht HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection J Immunol 150 1993 4659 4671
10. D. Sprengers, R.G. van der Molen, J.G. Kusters, R.A. De Man, H.G. Niesters, and S.W. Schalm Analysis of intrahepatic HBV-specific cytotoxic T-cells during and after acute HBV infection in humans J Hepatol 45 2006 182 189
11. Y. Wan, Y. Han, and J. Li The association between antigen-specific cytotoxic lymphocytes response and different clinical status in patients with hepatitis B Clin J Infect Dis 27 2009 287 291
12. J. Li, Y. Han, K. Jin, Y. Wan, S. Wang, and B. Liu Dynamic changes of cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and natural killer T (NKT) cells in patients with acute hepatitis B infection Virol J 8 2011 199
13. H.F. Löhr, S. Krug, W. Herr, S. Weyer, J. Schlaak, and T. Wölfel Quantitative and functional analysis of core-specific T-helper cell and CTL activities in acute and chronic hepatitis B Liver 18 1998 405 413
14. F.V. Chisari, M. Isogawa, and S.F. Wieland Pathogenesis of hepatitis B virus infection Pathol Biol (Paris) 58 2010 258 266
15. G.K. Sing, A. Ladhams, S. Arnold, H. Parmar, X. Chen, and J. Cooper A longitudinal analysis of cytotoxic T lymphocyte precursor frequencies to the hepatitis B virus in chronically infected patients J Viral Hepat 8 2001 19 29
16. D.C. Shieh, D.T. Lin, B.S. Yang, H.L. Kuan, and K.J. Kao High frequency of HLA-A*0207 subtype in Chinese population Transfusion 36 1996 818 821
17. J.M. Ellis, V. Henson, R. Slack, J. Ng, R.J. Hartzman, and C. Katovich Hurley Frequencies of HLA-A2 alleles in five U.S. population groups. Predominance of A*02011 and identification of HLA-A*0231 Hum Immunol 61 2000 334 340
18. D.R. Milich, F. Schödel, J.L. Hughes, J.E. Jones, and D.L. Peterson The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype J Virol 71 1997 2192 2201
19. b transgenic mice Immunology 121 2007 105 112
20. X. Chen, J. Lai, Q. Pan, Z. Tang, Y. Yu, and G. Zang The delivery of HBcAg via Tat-PTD enhances specific immune response and inhibits Hepatitis B virus replication in transgenic mice Vaccine 28 2010 3913 3919
21. W. Chen, M. Shi, F. Shi, Y. Mao, Z. Tang, and B. Zhang HBcAg-pulsed dendritic cell vaccine induces Th1 polarization and production of hepatitis B virus-specific cytotoxic T lymphocytes Hepatol Res 39 2009 355 365
22. J.H. Chen, Y.S. Yu, H.H. Liu, X.H. Chen, M. Xi, and G.Q. Zang Ubiquitin conjugation of hepatitis B virus core antigen DNA vaccine leads to enhanced cell-mediated immune response in BALB/c mice Hepat Mon 11 2011 620 628
23. R. Taylor BioInformatics and Molecular Analysis Section (BIMAS) HLA peptide binding predictions Available at: http://bimas.dcrt.nih.gov/molbio/hla- bind/index.html Accessed May 15, 2000
24. K.C. Parker, M.A. Bednarek, and J.E. Coligan Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains J Immunol 152 1994 163 175
25. M.A. Morse, Y. Deng, D. Coleman, S. Hull, E. Kitrell-Fisher, and S. Nair A phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen Clin Cancer Res 5 1999 1331 1338
26. A. Vitiello, D. Marchesini, J. Furze, L.A. Sherman, and R.W. Chesnut Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric humanmouse class I major histocompatibility complex J Exp Med 173 1991 1007 1015
27. + T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay Blood 98 2001 1872 1881
28. + T cell epitopes Blood 99 2002 2100 2106
29. Q. Liu, X. Shu, A. Sun, Q. Sun, C. Zhang, and H. An Plant-derived small molecule albaconol suppresses LPS-triggered proinflammatory cytokine production and antigen presentation of dendritic cells by impairing NF-kappaB activation Int Immunopharmacol 8 2008 1103 1111
30. B. Wang, H. Chen, X. Jiang, M. Zhang, T. Wan, and N. Li Identification of an HLA-A*0201-restricted CD8 + T-cell epitope SSp-1 of SARS-CoV spike protein Blood 104 2004 200 206
31. A. Penna, F.V. Chisari, A. Bertoletti, G. Missale, P. Fowler, and T. Giuberti Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen J Exp Med 174 1991 1565 1570
32. A. Bertoletti, F.V. Chisari, A. Penna, S. Guilhot, L. Galati, and G. Missale Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein J Virol 67 1993 2376 2380
33. B. Rehermann, D. Lau, J.H. Hoofnagle, and F.V. Chisari Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection J Clin Invest 97 1996 1655 1665
34. R. Bertoni, J. Sidney, P. Fowler, R.W. Chesnut, F.V. Chisari, and A. Sette Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis J Clin Invest 100 1997 503 513
35. L.M. Huang, C.Y. Lu, and D.S. Chen Hepatitis B virus infection, its sequelae, and prevention by vaccination Curr Opin Immunol 23 2011 237 243
36. Y.J. Tan Hepatitis B virus infection and the risk of hepatocellular carcinoma World J Gastroenterol 17 44 2011 4853 4857
37. M.L. Michel, and P. Tiollais Hepatitis B vaccines: protective efficacy and therapeutic potential Pathol Biol (Paris) 58 2010 288 295
38. P.C. Doherty, W. Allan, M. Eichelberger, and S.R. Carding Role of ab and gd T cell subsets in viral immunity Annu Rev Immunol 10 1992 123 151
39. E. Depla, A. Van der Aa, B.D. Livingston, C. Crimi, K. Allosery, and V. De Brabandere Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections J Virol 82 2008 435 450
40. B.D. Livingston, M. Newman, C. Crimi, D. McKinney, R. Chesnut, and A. Sette Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines Vaccine 19 2001 4652 4660
41. F.X. Ding, F. Wang, Y.M. Lu, K. Li, K.H. Wang, and X.W. He Multiepitope peptide-loaded virus-like particles as a vaccine against hepatitis B virus-related hepatocellular carcinoma Hepatology 49 2009 1492 1502
42. H.F. Lohr, G. Gerken, H.J. Schlicht, K.H. Meryer zum Buschenfelde, and B. Fleischer Low frequency of cytotoxic liver-infiltrating T lymphocytes specific for endogenous processed surface and core proteins in chronic hepatitis B J Infect Dis 168 1993 1133 1139
43. A. Penna, A. Bertoletti, A. Cavalli, A. Valli, G. Missale, and M. Pilli Fine specificity of the human T cell response to hepatitis B virus core antigen Arch Virol Suppl 4 1992 23 28
44. C. Ferrari, A. Penna, A. Bertoletti, and F. Fiaccadori Cell mediated immune response to hepatitis B virus nucleocapsid antigen Arch Virol Suppl 8 1993 91 101
45. Y. Sobao, K. Sugi, H. Tomiyama, S. Saito, S. Fujiyama, and M. Morimoto Identification of hepatitis B virus-specific CTL epitopes presented by HLA-A*2402, the most common HLA class I allele in East Asia J Hepatol 34 2001 922 929
46. H.G. Lee, J.S. Lim, K.Y. Lee, Y.K. Choi, I.S. Choe, and T.W. Chung Peptide-specific CTL induction in HBV-seropositive PBMC by stimulation with peptides in vitro: novel epitopes identified from chronic carriers Virus Res 50 1997 185 194
47. J. Liu, K.Y. Chen, and E.C. Ren Structural insights into the binding of hepatitis B virus core peptide to HLA-A2 alleles: towards designing better vaccines Eur J Immunol 41 2011 2097 2106
48. I. Carey, L. D'Antiga, S. Bansal, M.S. Longhi, Y. Ma, and I.R. Mesa Immune and viral profile from tolerance to hepatitis B surface antigen clearance: a longitudinal study of vertically hepatitis B virus-infected children on combined therapy J Virol 85 2011 2416 2428
49. S. Wang, Q. Han, G. Zhang, N. Zhang, Z. Li, and J. Chen CpG oligodeoxynucleotide-adjuvanted fusion peptide derived from HBcAg epitope and HIV-Tat may elicit favorable immune response in PBMCs from patients with chronic HBV infection in the immunotolerant phase Int Immunopharmacol 11 2011 406 411
50. D. Loirat, F.A. Lemonnier, and M.L. Michel Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization J Immunol 165 2000 4748 4755
51. L.G. Guidotti, T. Ishikawa, M.V. Hobbs, B. Matzke, R. Schreiber, and F.V. Chisari Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes Immunity 1996 425 436
52. L.G. Guidotti, R. Rochford, J. Chung, M. Shapiro, R. Purcell, and F.V. Chisari Viral clearance without destruction of infected cells during acute HBV infection Science 284 1999 825 829
53. G. Berke The CTL's kiss of death Cell 81 1995 9 12
54. J.A. Trapani Granzymes, cytotoxic granules and cell death: the early work of Dr. Jurg Tschopp Cell Death Differ 19 2012 21 27
55. K. Townsend, M. Sällberg, J. O'Dea, T. Banks, D. Driver, and S. Sauter Characterization of CD8 + cytotoxic T-lymphocyte responses after genetic immunization with retrovirus vectors expressing different forms of the hepatitis B virus core and e antigens J Virol 71 1997 3365 3374
56. L. Ochoa-Callejero, I. Otano, A. Vales, C. Olagüe, P. Sarobe, and J.J. Lasarte Identification of CD4 + and CD8 + T cell epitopes of woodchuck hepatitis virus core and surface antigens in BALB/c mice Vaccine 28 2010 5323 5331